| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.062 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |